IN8bio Inc. (INAB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    IN8bio Inc.

    NASDAQ: INAB · Real-Time Price · USD
    2.29
    0.20 (9.57%)
    At close: Sep 26, 2025, 3:59 PM
    2.30
    0.44%
    After-hours: Sep 26, 2025, 07:11 PM EDT

    IN8bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 2.65M 2.5M 1.1M 251K
    Gross Profit
    		 -2.65M -2.5M -1.1M -251K
    Operating Income
    		 -29.6M -30.34M -28.52M -14.65M
    Interest Income
    		 230K n/a n/a n/a
    Pretax Income
    		 -30.44M -30.01M -28.52M -14.65M
    Net Income
    		 -30.44M -30.01M -28.52M -14.65M
    Selling & General & Admin
    		 12.64M 13.51M 14.46M 7.31M
    Research & Development
    		 16.96M 16.83M 14.06M 7.35M
    Other Expenses
    		 -2.65M -2.5M n/a n/a
    Operating Expenses
    		 26.94M 27.84M 28.52M 14.65M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 29.6M 30.34M 28.52M 14.65M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 53.55M 29.86M 20.97M 18.78M
    Shares Outstanding (Diluted)
    		 53.55M 29.86M 20.97M 18.78M
    EPS (Basic)
    		 -0.57 -1 -1.36 -0.78
    EPS (Diluted)
    		 -0.57 -1 -1.36 -0.78
    EBITDA
    		 -27.78M -27.51M -27.42M -14.4M
    EBIT
    		 -30.44M -30.01M -28.52M -14.65M
    Depreciation & Amortization
    		 2.65M 2.5M 1.1M 251K

    Add to Watchlist